First “ERAvsCORONA” Action Plan: 10 Priorities for Coordinated Research and Innovation Actions

covid 4948866 1280

On 26 March 2020, the President of the European Commission, Ursula von der Leyen and the President of the European Council, Charles Michel stated that “Europe stands ready to set up an international online pledging event to ensure adequate funding to develop and deploy a vaccine against COVID-19." 

A videoconference with EU Commissioner for innovation, research, culture, education and youth was held on 7 April to exchange views on how to respond to the COVID-19 crisis, including the financing of European research and innovation projects and the sharing of scientific data and infrastructure among research and innovation centres. The result of the conference is agreed on the first 10 short-term coordinated actions. 

The first 10 priority actions of the first ERAvsCorona Action Plan are: 

  1. Coordination of R&I funding against the Coronavirus
    This action aims at giving national authorities a possibility to work closely and align activities through Programme level cooperation

  2. Extending and supporting large EU wide clinical trials for clinical management of Coronavirus patients
    This action aims at gathering additional funding to extend and support the implementation of large-scale, multi-centric clinical trials across Europe.

  3. New funding for innovative and rapid health-related approaches to respond to coronavirus and deliver quick results relevant to society and a higher level of preparedness of health systems
    This action aims at funding innovative approaches for researchers and innovators to deliver quick results relevant to society focussing on (1) Social and economic impacts of the outbreak response; (2) Medical technologies and ICT-applications; (3) Health systems preparedness (including manufacturing).

  4. Increasing support for innovative companies
    This action aims at increasing support to the recently closed Horizon 2020 European Innovation Council pilot Accelerator using the opportunity of the bottom-up call where more than 1,000 coronavirus related applications have been received (out of a global number of around 4,000) to support the best applications relating to the coronavirus. It also aims at increasing support to research & innovation financial instruments addressing coronavirus related issues. This would assist with the increasing demand for financial support notably for rapid vaccines development and deployment / upscaling of good manufacturing practice production facilities of EU enterprises. It also includes establishing a Coronavirus European Innovation Council Platform for matchmaking services with dedicated groups and matchmaking services for start-ups and SMEs to exchange ideas on coronavirus innovations and connect with investors, public procurers, corporations and others.

  5. Creating opportunities for other funding sources to contribute to R&I actions on Coronavirus
    This action aims at awarding Seals of Excellence for coronavirus relevant innovations by SMEs/startups evaluated as excellent, but not selected for funding under the European Innovation Council calls. It would also request the consent of SMEs/startups to provide their contact details to Structural Fund managing authorities. Under this action, favourable treatment of state aid to COVID19 Seals of Excellence applies. Additional funding sources, e.g. national/regional funding, private foundations, InvestEU etc will be explored.

  6. Establish a one-stop-shop for Coronavirus R&I funding
    An “ERA Corona platform” will provide a complete overview of all ongoing R&I funding initiatives on the Coronavirus.
    See more here

  7. Establish an ad-hoc High-Level R&I Task Force on the Coronavirus
    Without duplicating existing structures, such a new ad-hoc High-Level R&I Task Force could advise on possible R&I actions of EU relevance on identified medium and long-term priorities and communicate about coordinated R&I actions to the general public.

  8. Access to Research Infrastructures
    The availability of the services provided by Research Infrastructures (analytical facilities, biological samples, reagents, pathogen labs, regulatory support, social science Research Infrastructures etc.) and of the data they hold (e.g. for the re-testing of raw data and assessing the societal effects and effectiveness of pandemic responses) is vital for researchers working on the coronavirus. New services (including High-Performance Computing and Artificial Intelligence) and datasets are being brought on stream and it is important to match supply and demand across borders.

  9. Research data sharing platform
    This action aims to establish a European data exchange platform for SARS-CoV-2 and coronavirus-related information exchange, connected to the European Open Science Cloud. This will allow quick sharing of research data and results to accelerate discovery. Researchers should be required to provide immediate and fully open access and to share research outcomes (data, models, workflows, results) that are as FAIR as possible in real-time.

  10. Pan-EU Hackathon to mobilise European innovators and civil society
    The Commission has given patronage to a pan-European Hackathon (#EUvsVirus) which will be organised through a coalition with the organisers of the hackathons held in Austria, Belgium, Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Malta, The Netherlands, Poland, Portugal, Romania, Slovenia, Spain, and Sweden. This Hackathon is expected to shorten the time to deployment of innovative solutions developed by start-ups and policymakers since innovators will be able to leverage the work already done by other innovators in Europe instead of starting from scratch or redoing the work done already by other innovators. It is also expected to provide information to hospitals and public administrations on the existing innovative solutions in the other Member States. The planned date for the Hackathon is 24-26 April 2020.

Source: European Commission

© Copyright INNOVA

Privacy Policy

Legal Note